8 employees
Bionsight is a drug discovery company that uses Chemoproteomics interweaved with AI to speed up the drug development process.
2019
$5.5M
from 3 investors over 3 rounds
Bionsight raised $5.5M on August 16, 2023
Investors: DSC Investment and SV Investment
Bionsight raised undisclosed on May 1, 2021
Investors: TIPS Town